GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BIO-FD&C Co Ltd (XKRX:251120) » Definitions » ROCE %

BIO-FD&C Co (XKRX:251120) ROCE % : 9.01% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is BIO-FD&C Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. BIO-FD&C Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 9.01%.


BIO-FD&C Co ROCE % Historical Data

The historical data trend for BIO-FD&C Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIO-FD&C Co ROCE % Chart

BIO-FD&C Co Annual Data
Trend Dec15 Dec16 Dec18 Dec19 Dec20 Dec21 Dec22
ROCE %
Get a 7-Day Free Trial 3.68 29.36 23.44 22.02 16.01

BIO-FD&C Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.17 11.56 11.86 20.62 9.01

BIO-FD&C Co ROCE % Calculation

BIO-FD&C Co's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=5552.295/( ( (23040.032 - 6750.612) + (59035.811 - 5981.27) )/ 2 )
=5552.295/( (16289.42+53054.541)/ 2 )
=5552.295/34671.9805
=16.01 %

BIO-FD&C Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=5340.964/( ( (62812.541 - 4090.508) + (63951.451 - 4136.189) )/ 2 )
=5340.964/( ( 58722.033 + 59815.262 )/ 2 )
=5340.964/59268.6475
=9.01 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BIO-FD&C Co  (XKRX:251120) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


BIO-FD&C Co ROCE % Related Terms

Thank you for viewing the detailed overview of BIO-FD&C Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


BIO-FD&C Co (XKRX:251120) Business Description

Traded in Other Exchanges
N/A
Address
30, Songdomirae-ro, Yeonsu-gu, 509-512, B07, A-dong, Smartvalley, Incheon, KOR
BIO-FD&C Co Ltd is engaged in dealing with anti-aging and health materials using sustainable bio-cultivation technology. Its products include Plant cell, Peptide, Herbal Extract and Biomolecule.

BIO-FD&C Co (XKRX:251120) Headlines

No Headlines